Concepedia

Paolo Manca

PM

29

Publications

1.2K

Citations

21

H-Index

2004

Active since

Affiliations

Fondazione IRCCS Istituto Nazionale dei Tumori(Current)

Istituti di Ricovero e Cura a Carattere Scientifico

Istituto Oncologico Veneto

Azienda Ospedaliera Universitaria Pisana

University of Pisa

Paolo Manca is an author at Fondazione IRCCS Istituto Nazionale dei Tumori specializing in medicine, oncology, and pathology.

ORCID

Top concepts

Publications per year

2004–2024

29

Publications

29

Circulating tumor DNA to guide rechallenge with panitumumab in metastatic colorectal cancer: the phase 2 CHRONOS trial

Andrea Sartore‐Bianchi, Filippo Pietrantonio, Sara Lonardi et al. · Nature Medicine · 2022 · 237 citations · Full text

Multidisciplinary molecular tumour board: a tool to improve clinical practice and selection accrual for clinical trials in patients with cancer

Christian Rolfo, Paolo Manca, Roberto Salgado et al. · ESMO Open · 2018 · 105 citations · Full text

Extracellular vesicle PD-L1 dynamics predict durable response to immune-checkpoint inhibitors and survival in patients with non-small cell lung cancer

Diego de Miguel‐Pérez, Alessandro Russo, Óscar Arrieta et al. · Journal of Experimental & Clinical Cancer Research · 2022 · 97 citations · Full text

Phase II study of anti-EGFR rechallenge therapy with panitumumab driven by circulating tumor DNA molecular selection in metastatic colorectal cancer: The CHRONOS trial.

Andrea Sartore‐Bianchi, Filippo Pietrantonio, Sara Lonardi et al. · Journal of Clinical Oncology · 2021 · 59 citations

, , +14

Immune checkpoint inhibitors for POLE or POLD1 proofreading-deficient metastatic colorectal cancer

Margherita Ambrosini, Benoı̂t Rousseau, Paolo Manca et al. · Annals of Oncology · 2024 · 56 citations · Full text

Rows per page

1–5 of 29